Clinical Trial

Compass 3: A Novel Transition Program to Reduce Disability After Stroke

Study acronym: COMPASS 3
Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates a program designed to help individuals transition from inpatient rehabilitation to home following an ischemic or hemorrhagic stroke. Half of the participants will receive a stroke education program while the other half will receive an environmental modifications program.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-07-14; most recent amendment 2026-02-12.
Status change: Not Yet Recruiting → Recruiting 2025-11-13
Trial Details
NCT Number NCT07069660
Lead Sponsor Washington University School of Medicine
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Stroke
Enrollment 520 participants
Start Date 2025-09-29
Primary Completion 2030-03-31 (estimated)
Study Completion 2030-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-13